|
Aurobindo Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
69411.60 Cr.
|
P/BV
|
2.13
|
Book Value (Rs.)
|
562.21
|
|
52 Week High/Low (Rs.)
|
1356/1010
|
FV/ML
|
1/1
|
P/E(X)
|
19.91
|
|
Bookclosure
|
08/08/2025
|
EPS (Rs.)
|
60.02
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 59.81 | 54.16 | 32.90 | 45.19 | 91.05 |
| Diluted EPS (Rs.) | 59.81 | 54.16 | 32.90 | 45.19 | 91.05 |
| Cash EPS (Rs.) | 88.92 | 80.35 | 54.34 | 64.94 | 109.99 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 562.21 | 509.49 | 458.30 | 419.42 | 374.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 562.21 | 509.49 | 458.30 | 419.42 | 374.28 |
| Revenue From Operations / Share (Rs.) | 546.21 | 495.00 | 424.23 | 400.33 | 422.85 |
| PBDIT / Share (Rs.) | 124.05 | 109.24 | 68.43 | 80.34 | 97.53 |
| PBIT / Share (Rs.) | 95.65 | 83.27 | 47.19 | 61.11 | 79.52 |
| PBT / Share (Rs.) | 87.78 | 75.05 | 44.79 | 58.10 | 126.28 |
| Net Profit / Share (Rs.) | 60.52 | 54.38 | 33.10 | 45.71 | 91.98 |
| NP After MI And SOA / Share (Rs.) | 60.02 | 54.16 | 32.90 | 45.20 | 91.05 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 22.71 | 22.06 | 16.13 | 20.06 | 23.06 |
| PBIT Margin (%) | 17.51 | 16.82 | 11.12 | 15.26 | 18.80 |
| PBT Margin (%) | 16.06 | 15.16 | 10.55 | 14.51 | 29.86 |
| Net Profit Margin (%) | 11.08 | 10.98 | 7.80 | 11.41 | 21.75 |
| NP After MI And SOA Margin (%) | 10.98 | 10.94 | 7.75 | 11.29 | 21.53 |
| Return on Networth / Equity (%) | 10.67 | 10.63 | 7.18 | 10.77 | 24.32 |
| Return on Capital Employeed (%) | 15.82 | 14.84 | 9.73 | 13.89 | 20.09 |
| Return On Assets (%) | 7.00 | 7.03 | 4.83 | 7.80 | 15.75 |
| Long Term Debt / Equity (X) | 0.04 | 0.07 | 0.02 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.24 | 0.21 | 0.18 | 0.09 | 0.22 |
| Asset Turnover Ratio (%) | 0.66 | 0.68 | 0.67 | 0.69 | 0.78 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.85 | 1.98 | 1.87 | 2.22 | 1.86 |
| Quick Ratio (X) | 1.13 | 1.18 | 1.13 | 1.30 | 1.01 |
| Inventory Turnover Ratio (X) | 3.12 | 1.18 | 1.20 | 0.88 | 0.99 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 22.79 | 9.95 | 4.39 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 13.85 | 6.98 | 3.66 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 77.21 | 90.05 | 95.61 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 86.15 | 93.02 | 96.34 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 15.76 | 22.09 | 28.54 | 96.77 | 76.71 |
| Interest Coverage Ratio (Post Tax) (%) | 8.69 | 12.66 | 14.80 | 58.70 | 35.56 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 67055.18 | 63875.80 | 29138.94 | 37374.61 | 51145.96 |
| EV / Net Operating Revenue (X) | 2.11 | 2.20 | 1.17 | 1.59 | 2.06 |
| EV / EBITDA (X) | 9.31 | 9.98 | 7.27 | 7.94 | 8.95 |
| MarketCap / Net Operating Revenue (X) | 2.12 | 2.20 | 1.22 | 1.67 | 2.08 |
| Retention Ratios (%) | 0.00 | 0.00 | 77.20 | 90.04 | 95.60 |
| Price / BV (X) | 2.06 | 2.14 | 1.13 | 1.59 | 2.36 |
| Price / Net Operating Revenue (X) | 2.12 | 2.20 | 1.22 | 1.67 | 2.08 |
| EarningsYield | 0.05 | 0.04 | 0.06 | 0.06 | 0.10 |
